Similarly, another study of a pediatric IBD cohort showed significant correlation between microbiota composition and disease severity, with resolution of dysbiosis in patients responding to anti-tumor necrosis factor (TNF) therapy [48]. The gene discussed is TNF; the disease is inflammatory bowel disease.